Altered higher brain function in PACAP-knockout mice.

Accession number;04A0322992
Title;Altered higher brain function in PACAP-knockout mice.
Author; SHINTANI NORIHITO (Osaka Univ., Graduate School of Pharmaceutical Sciences, JPN) HASHIMOTO HITOSHI (Osaka Univ., Graduate School of Pharmaceutical Sciences, JPN) BABA AKEMICHI (Osaka Univ., Graduate School of Pharmaceutical Sciences, JPN)
Journal Title;Folia Pharmacologica Japonica
Journal Code:G0740A
ISSN:0015-5691
VOL.123;NO.4;PAGE.274-280(2004)
Figure&Table&Reference;FIG.1, TBL.3, REF.35
Pub. Country;Japan
Language;Japanese
Abstract;Pituitary adenylate cyclase-activating polypeptide (PACAP) is a neuropeptide that functions as not only a neurotransmitter/neuromodulator but also a neurotrophic factor. To assess the roles of endogenous PACAP, several groups including ours have independently produced mice with targeted mutations in the PACAP gene. The phenotypes of the mutant mice both confirm and extend our knowledge of the physiological roles of PACAP in the central nervous system as well as many peripheral organs. In this review, we briefly summarize the roles of PACAP in higher brain function, which have been proposed by the studies using the mutant mice as well as histological and pharmacological approaches. (author abst.)
FULLTEXT